RFA
GSK icon

Resurgent Financial Advisors’s GSK GSK Stock Holding History

Resurgent Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,934
Closed -$71.7K – 306
2023
Q4 		$71.7K Hold
1,934
– – 0.04% 283
2023
Q3 		$70.1K Buy
1,934
+146
+8% +$5.18K 0.05% 278
2023
Q2 		$63.7K Hold
1,788
– – 0.04% 295
2023
Q1 		$63.6K Sell
1,788
-1,092
-38% -$38.2K 0.04% 293
2022
Q4 		$101K Sell
2,880
-4,113
-59% -$137K 0.05% 308
2022
Q3 		$206K Buy
+6,993
New +$265K 0.14% 187

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Resurgent Financial Advisors's GSK Position: Q1 2024 in Review

Resurgent Financial Advisors sold out of GSK (GSK) in Q1 2024, closing a stake of 1,934 shares — an estimated $71.7K sold.

Resurgent Financial Advisors first reported a position in GSK in Q3 2022 and held it in 6 quarters. The position peaked at $206K in Q3 2022. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • Resurgent Financial Advisors reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
  • Resurgent Financial Advisors sold 1,934 GSK shares in Q1 2024, an estimated $71.7K.
  • Resurgent Financial Advisors first reported a position in GSK in Q3 2022 and held it in 6 quarters.
  • Resurgent Financial Advisors's GSK position peaked at $206K in Q3 2022.
  • 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Resurgent Financial Advisors's 13F filing for Q1 2024, filed 10 May 2024.